Provided by Tiger Trade Technology Pte. Ltd.

Acrivon Therapeutics, Inc.

1.77
-0.0600-3.28%
Volume:247.31K
Turnover:442.19K
Market Cap:75.76M
PE:-0.94
High:1.90
Open:1.85
Low:1.76
Close:1.83
52wk High:3.56
52wk Low:1.27
Shares:42.80M
Float Shares:25.69M
Volume Ratio:1.34
T/O Rate:0.96%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.8800
EPS(LYR):-2.0151
ROE:-64.63%
ROA:-38.02%
PB:0.87
PE(LYR):-0.88

Loading ...

Aug 25, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 13, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Aug 12, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 12, 2026

Major Issues Report

Form 8-K - Current report
Aug 12, 2026

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Jun 17, 2026

Major Issues Report

Form 8-K - Current report
May 15, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
May 13, 2026

Major Issues Report

Form 8-K - Current report
May 13, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Mar 19, 2026

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 19, 2026

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 19, 2026

Major Issues Report

Form 8-K - Current report
Mar 03, 2026

Major Issues Report

Form 8-K - Current report
Feb 27, 2026

Major Issues Report

Form 8-K - Current report
Jan 08, 2026

Major Issues Report

Form 8-K - Current report
Jan 08, 2026

Major Issues Report

Form 8-K - Current report
Nov 13, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 13, 2025

Major Issues Report

Form 8-K - Current report
Sep 05, 2025

Major Issues Report

Form 8-K - Current report
Aug 13, 2025

Major Issues Report

Form 8-K - Current report